Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE (0.09%), DAX (0.54%), CAC40 (0.43%)

Mar 17 ,2026

  • Synopsis

    • European equity markets set to open lower, while Asia equities largely higher Tuesday although many now off their peaks. Prominent gains in Japan's benchmarks faded somewhat but Topix and Nikkei still higher. Hong Kong also hanging on to gains but off peaks, mainland China boards now down.

    • Middle East energy situation still in focus amid as markets assess feasibility of US-led efforts to reopen Strait of Hormuz. Several US allies rebuffed Trump's request to send vessels to facilitate shipping though he also flagged some countries will participate. Success in unblocking Hormuz still seen as main relief valve for oil markets while Iranian attacks on Middle East energy infrastructure (and resulting impact on production) and lack of visibility towards ceasefire (officials expect fighting to last weeks) remain the other overhangs.

    • Elsewhere, President Trump confirmed he requested China delay summit with President Xi by a month or so, citing preoccupation with Iran conflict. US and China economic officials held second day of talks on Monday with USTR Greer mentioning possibility of a US-China Board of Trade to manage trade and economic ties. Monday talks described as "constructive and Xinhua readout noting two sides reached preliminary consensus on some issues. However, Beijing expressed opposition to S.301 probe targeting China and other nations.

    • Also on today's agenda, in politics, EU environment ministers will hold a policy debate on the amendment to the regulation on CO2 emission standards for cars and vans. UK parliamentary committee topics include The OBR: 15 years on at 9:45GMT, personalised medicine and AI at 10:15, Ministry of Defence Annual Report and Accounts at 10:30, the cost of energy at 15:00. EUROPE 2026 Conf, jointly organised by DIE ZEIT, Handelsblatt, others (through Wed), featuring, among others, EP President Metsola and Germany's digital affairs (Wildberger) and foreign (Wadephul) ministers. Amongst other events Tue, Euractiv Agrifood policy conf. speaker include EU's Hansen at 9:30CET and EU's Kallas delivers the keynote speech at EEAS 2026 Counter FIMI Conf, Zaharieva participates in Clean Aviation Annual Forumand Hoekstra delivers the closing speech at the EU tax symposium. Ireland's Taoiseach, the Tánaiste and representatives of the State travel (St. Patrick's Day program) to more than 50 countries. Norway's minister of agriculture and food Sandtrøen delivers speech at 11:00CET to the Sustainable Feed Conf. and at 12:30 the minister for foreign affairs Eide is a panellist at the annual conf . of the Norwegian Shipowners' Assn.

    • In central banks, SNB to publish 2025 Annual and Sustainability Reports and BOE's Evans delivers a speech at 11:30GMT at the Univ. of Leeds 'Modernising the liquidity framework for banks and building societies'. Bundesbank's Nagel gives a speech at 16:15CET at Baden-Württemberg Cooperative State Univ and Theurer panellist at 18:00 at event organised by Friedrich Naumann Foundation.

    • European macro data releases out today include, Germany Mar economic sentiment index - ZEW, Italy Feb final CPI, Switzerland Feb PPI.

    • In earnings new, DACHs names kicked off the session with Fraport (FRA.GR) reporting FY earnings numbers, whilst Sartorius indicated it expects medium-term organic sales revenue growth in constant currencies of 8% to 11% ahead of it's CMD today. In France, BNP Paribas (BNP.FP), Kering (KER.FP) and Sartorius Stedim Biotech (DIM.FP) issued presentations in connection with their CMD, whilst Aeroport de Paris (ADP.FP) released Feb traffic figures.

  • Politics/Macro/World News

    • Naval escorts will not guarantee safe passage through Strait of Hormuz, says IMO chief -- FT

    • Europe rejects Trump's demand to help clean up Hormuz mess -- Politico

    • Iran renews attacks on US Gulf allies, Trump says that was not expected - Reuters

    • IMF Raises Alarm Over Aid to Ukraine With Parliament in Gridlock - Bloomberg

    • French far right struggles to deliver its decisive breakthrough -- Politico

    • Reeves vows to stop UK tech from 'drifting abroad' - BBC

  • Top company news

    • Earnings/updates

      • DACHs

        • SRT3.GR (Sartorius) -- expects medium-term organic sales revenue growth in constant currencies of 8% to 11% -- CMD

        • MED.SW (Medartis Holding) -- reports FY core EBITDA CHF48.8M vs FactSet CHF46.2M [3 est, CHF44.9-47.6M]

        • SPG.GR (Springer Nature) -- reports FY adjusted EPS €1.93 vs FactSet €1.70 [8 est, €1.61-1.76]

        • NB2.GR (Northern Data) -- reports preliminary FY25 EBIT (€463M) vs year-ago (€69M)

        • BSL.GR (Basler) -- reports preliminary FY EBIT €17.7M vs FactSet €19.4M [2 est, €18-20.7M]

        • FRA.GR (Fraport) -- reports FY EPS €4.67 vs FactSet €4.72 [20 est, €3.99-5.15]; Group net profit is expected to decline in 2026

        • BCGE.SW (Banque Cantonal de Geneve) -- reports FY net income CHF220.9M vs year-ago CHF219.2M

      • France

        • DIM.FP (Sartorius Stedim Biotech) -- sets new medium term targets at CMD: targets organic sales revenue growth of +9-12% per year in constant currencies

        • KER.FP (Kering) -- announces a new segmentation of its businesses

        • BNP.FP (BNP Paribas) -- sees ~€350B of cumulative net inflows targeted by 2030; revenue CAGR of ~+4% from 2025 to 2030 -- AM CMD

        • ADP.FP (Aeroport de Paris) -- reports Group Feb traffic 26.7M, +0.6% y/y

      • Southern Europe

        • MOL.IM (Moltiply Group) -- reports FY net income €28.8M vs FactSet €60.4M [4 est, €56.4-66.2M]

      • Nordics

        • SITOWS.FH (Sitowise Group) -- announces new mid-term strategic focus areas and financial targets

      • Also due to report today:

        • Earnings:

          • DACHs: Mensch & Maschine Software (MUM.GR), Dermapharm (SMP.GR), Mayr-Melnhof Karton (MMK.AV)

          • France: Bolloré (BOL.FP), Virbac (VIRP.FP)

          • Southern Europe: A2A (A2A.IM), Pharmanutra (PHN.IM)

          • UK: Prudential (PRU.LN), Primary Health Properties (PHP.LN), Trustpilot Group (TRST.LN), Harworth Group (HWG.LN), BOKU (BOKU.LN), IP Group (IPO.LN), Mortgage Advice Bureau (MAB1.LN), Ashtead Technology Holdings (AT.LN), Yu Group (YU.LN), Essentra (ESNT.LN), Science Group (SAG.LN), Fintel (FNTL.LN), Zotefoams (ZTF.LN), Midwich Group (MIDW.LN), Eagle Eye Solutions Group (EYE.LN), The Pebble Group (PEBB.LN), STV Group (STVG.LN)

          • Other: Mavi Giyim Sanayi ve Ticaret (MAVI.E.TI)

        • Trading Update:

          • UK: Sthree (STEM.LN)

          • Traffic: VICI (DG.FP)

        • CMD/Events: Attendo (ATT.SS), Kojamo (KOJAMO.FH)

    • M&A

      • KNEBV.FH (Kone) -- reportedly in talks to acquire TK Elevator -- Bloomberg

      • (OTHER) SDG.FP (Synergie) -- closes the acquisition of a majority stake in Agilus Work Solutions

    • Healthcare

      • ROG.SW (Roche Holding) -- Roche launches NVIDIA AI factory to accelerate development of new therapeutics and diagnostics solutions

      • SN.LN (Smith & Nephew) -- SEC filing: SCHEDULE 13D/A (Filed by Cevian Capital II GP LTD)

      • RYTM (Rhythm Pharmaceuticals) -- announces topline results from Phase 3 EMANATE trial; four substudies did not meet primary endpoints

      • RYTM (Rhythm Pharmaceuticals) -- Post-close news (and conference call)

      • TECN.SW (Tecan Group) -- announces a strategic collaboration with NVIDIA focused on providing the AI-enabled platforms that Data-Driven Labs

      • TECN.SW (Tecan Group) -- Tecan announces strategic collaboration with NVIDIA focused on providing the AI-enabled platforms

    • Other

      • VOLCAR.B.SS (Volvo Car) -- Volvo reported to be discontinuing US sales of EX30 EV model next year - Business Insider

      • OPAP.GA (Allwyn) -- OPAP Holding completes cross-border conversion

      • OPAP.GA (Allwyn) -- OPAP Holding S.A. announces new members of the board

      • AKER.NO (Aker ASA) -- Aker makes annoucnement related to Nscale acquisition of American Intelligence & Power Corporation and signing of LOI with Microsoft covering 430,000 GPUs

      • KER.FP (Kering) -- announces the creation of Jewelry, a new entity designed to structure and accelerate the growth of its Jewelry business

      • DG.FP (VINCI SA) -- selected for design-build contract for UK fusion energy project

      • P911.GR (Porsche) -- Street Takeaways - Porsche FY25 and Q4 Results

      • Airbus confirms Atlas Air Worldwide order for Airbus A350F freighters (16-Mar)

      • Regional Gaming Revenues - New Jersey February 2026

      • Rio Tinto announces Resolution Copper completes land exchange with United States Forest Service (USFS)

      • UK Atomic Energy Authority makes nuclear project selectinons; OpenAI, Anthropic consider PE partnerships in intraday themes (16-Mar)

  • Key rating changes

    • Upgrades

      • NESTE.FH (Neste) -- to overweight from equal weight at Barclays

    • Downgrades

      • UTG.LN (UNITE Group) -- to equal weight from overweight at Barclays

    • Initiations

      • COTN.SW (COMET Holding) -- overweight at JPMorgan

  • Data

    • Nikkei (0.09%) to 53700.39

    • Hang Seng +0.25% to 25897.73

    • Shanghai Composite (0.72%) to 4055.46

    • S&P futures (32.0) vs prior close of 6755.5

    • €-$ (0.0031) or (0.27%) to 1.1476

    • $-¥ +0.31 or +0.20% to 159.37

    • €-¥ (0.11) or (0.06%) to 182.88

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.